Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) Debt to Equity (2023 - 2026)

BioAge Labs' Debt to Equity history spans 3 years, with the latest figure at $0.01 for Q4 2025.

  • On a quarterly basis, Debt to Equity fell 63.01% to $0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.01, a 63.01% decrease, with the full-year FY2025 number at $0.01, down 63.01% from a year prior.
  • Debt to Equity hit $0.01 in Q4 2025 for BioAge Labs, down from $0.01 in the prior quarter.
  • Over the last five years, Debt to Equity for BIOA hit a ceiling of $0.03 in Q3 2024 and a floor of -$0.08 in Q4 2023.
  • Historically, Debt to Equity has averaged $0.01 across 3 years, with a median of $0.02 in 2025.
  • Biggest five-year swings in Debt to Equity: soared 132.13% in 2024 and later crashed 63.01% in 2025.
  • Tracing BIOA's Debt to Equity over 3 years: stood at -$0.08 in 2023, then surged by 132.13% to $0.03 in 2024, then crashed by 63.01% to $0.01 in 2025.
  • Business Quant data shows Debt to Equity for BIOA at $0.01 in Q4 2025, $0.01 in Q3 2025, and $0.02 in Q2 2025.